Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2008; 133(12): 591-594
DOI: 10.1055/s-2008-1067291
DOI: 10.1055/s-2008-1067291
Kommentar | Commentary
Kardiologie, Pathophysiologie
© Georg Thieme Verlag KG Stuttgart · New York
Kardiologische Optionen der Akutprotektion des reperfundierten Myokards
Cardiological options for acute protection of the reperfused myocardiumFurther Information
Publication History
eingereicht: 3.12.2008
akzeptiert: 14.2.2008
Publication Date:
12 March 2008 (online)

Schlüsselwörter
Myokardinfarkt - Reperfusion - Postkonditionierung
Key words
myocardial infarction - reperfusion - postconditioning
Literatur
- 1 Armstrong P W, Adams P X, Al-Khalidi H R, Hamm C, Holmes D, O’Neill W, Todaro T G, Vahanian A, van de Werf F, Granger C B. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Amer Heart J. 2005; 149 (3) 402-7
- 2 Darling C E, Solari P B, Smith C S, Furman M I, Przyklenk K. ‘Postconditioning’ the human heart: multiple balloon inflations during primary angioplasty may confer cardioprotection. Basic Res Cardiol. 2007; 102 (3) 274-278
- 3 Heusch G, Schulz R. Ischämische Prä- und Postkonditionierung. Dtsch Med Wochenschr. 2006; 39 2169-75
- 4 Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007; 370 (9597) 1483-93
- 5 Murry C E, Jennings R B, Reimer K A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74 (5) 1124-36
- 6 Philipp S, Yang X -M, Cui L, Davis A, Downey J M, Cohen M V. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade. Cardiovasc Res. 2006; 70 (2) 308-14
- 7 Roe M. ACC 07: Die DELTA MI-Studie. Herz. 2007; 32 250
- 8 Ross A M, Gibbons R J, Stone G W, Kloner R A, Alexander R W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol. 2005; 45 (11) 1775-80
- 9 Staat P, Rioufol G, Piot C, Cottin Y, Cung T T, L’Huillier I, Aupetit J F, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M. Postconditioning the human heart. Circulation. 2005; 112 (14) 2143-8
- 10 Zhao Z Q, Corvera J S, Halkos M E, Kerendi F, Wang N -P, Guyton R A, Vinten-Johansen J. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol. 2003; 285 H579-H588
Dr. med. Frank Breuckmann
Klinik für Kardiologie, Westdeutsches Herzzentrum Essen, Universität Duisburg-Essen
Hufelandstr. 55
45122 Essen
Phone: 0201/723-4888
Fax: 0201/723-5401
Email: frank.breuckmann@uk-essen.de